Chattanooga Times Free Press

Saving the orange tree

- By Henry I. Miller

Americans might soon need to get used to apple or grape juice as their breakfast drink of choice — unless, that is, they’re willing to pay exorbitant prices for orange juice. Or maybe scientists, plant breeders and farmers will manage to save the day, using two critical but often-disparaged technologi­es: chemical pesticides in the short run and genetic engineerin­g in the longer term.

The pestilence that is devastatin­g Florida citrus is a disease called citrus greening. It is caused by a bacterium, Candidatus Liberibact­er asiaticus, which is spread by small insects called psyllids. The bacteria infect the tree’s phloem, thereby blocking the flow of nutrients, causing yellow mottling on the leaves and asymmetric­al, bitter fruit that never ripens. Infected trees die within about five years, during which time they serve as a reservoir for psyllids to spread the disease further. There is no known cure, but it can be slowed by frequent spraying with large amounts of chemical pesticides.

Greening has seriously compromise­d citrus production in a number of countries in Asia, Africa, the Indian subcontine­nt and the Arabian peninsula and was discovered in July 2004 in Brazil. In 2005, the disease was found in south Florida and has since spread to sites in all counties that grow commercial citrus in the state. It has also been found in California but is not yet widespread here.

Several strategies that use genetic engineerin­g techniques are being pursued to produce orange trees resistant

In 2005, the disease (citrus greening) was found in south Florida and has since spread to sites in all counties that grow commercial citrus in the state.

to C. Liberibact­er. The approaches range from incorporat­ing a gene from spinach or pigs into orange plants to using viruses — bacterioph­ages — that prey on bacteria.

Some of these strategies have been used with stunning success in other crops to enhance resistance to various pests and diseases and to introduce other characteri­stics. The vast majority of corn, cotton, canola, sugar beet and soy grown in the United States have been geneticall­y engineered with modern molecular techniques. And for more than a decade, most Hawaiian papayas have been engineered to resist a pest that in the 1990s was devastatin­g the state’s production.

More to the point, neither farmers nor consumers are unfamiliar with foods that have been geneticall­y modified in some way. With the exception of wild game, wild berries, wild mushrooms and fish and shellfish, most everything in our diet has been geneticall­y improved by one technique or another. (Even some heirloom fruits and vegetables.) Since the 1930s, plant breeders have performed “wide cross” hybridizat­ions in which large numbers of “alien” genes are moved from one species or genus to another to create plant varieties that otherwise cannot and do not exist in nature. Common commercial varieties include tomato, potato, oat, rice and wheat — hardly fearsome “Frankenfoo­ds.”

However, even with modern molecular techniques, the genetic engineerin­g of trees is a slow process, and citrus growers are desperate for solutions that will buy them time until disease-resistant trees can be developed and tested and are yielding fruit. One promising approach focuses on killing the prolific psyllids.

Currently, there is only one effective treatment: a soil drench of neonicotin­oid (“neonic”) pesticide (derived from the naturally occurring nicotine found in plants) at the base of the young citrus tree’s trunk. This enables the chemical to be taken up through the roots, which keeps it from affecting other flying insects or pollinator­s, as spraying can.

If we are to preserve Florida’s $9-billion orange juice industry — and citrus crops in California and Texas when the disease spreads further — we will need to rely on the best technologi­es available. That means coming to terms with safe and rational genetic engineerin­g and the innovative applicatio­ns of systemic neonic pesticides.

ABOUT THE WRITER

Henry I. Miller, a physician and former director of the FDA’s Office of Biotechnol­ogy, is a fellow at Stanford University’s Hoover Institutio­n.

Newspapers in English

Newspapers from United States